AZACYTIDINE UPREGULATES PERFORIN EXPRESSION IN CYTOTOXIC T AND NATURAL KILLER CELLS OF RESPONDING PATIENTS WITH MYELODYSPLASTIC SYNDROME (MDS)

被引：0
|
作者：
Miltiades, P. [1 ]
Lamprianidou, E. [1 ]
Vassilakopoulos, T. P. [2 ]
Papageorgiou, S. G. [3 ]
Galanopoulos, A. G. [4 ]
Vakalopoulou, S. [5 ]
Garypidou, V. [5 ]
Nakou, E. [1 ]
Papadaki, H. A. [6 ]
Spanoudakis, E. [1 ]
Tsatalas, C. [7 ]
Kotsianidis, I. [1 ]
机构：
[1] Democritus Univ Thrace, Univ Hosp Alexandroupolis, Dept Hematol, Alexandroupolis, Greece
[2] Univ Athens, Laikon Gen Hosp, Dept Hematol, Athens 11528, Greece
[3] Attikon Univ, Dept Internal Med 2, Hematol Unit, Gen Hosp, Athens, Greece
[4] G Gennimatas Hosp, Dept Clin Hematol, Athens, Greece
[5] Aristotle Univ Thessaloniki, Hippokrat Hosp, Propedeut Dept Internal Med 2, GR-54006 Thessaloniki, Greece
[6] Univ Hosp Heraklion, Dept Hematol, Iraklion, Greece
[7] Aristotle Univ Thessaloniki, AHEPA Hosp, Dept Hematol, GR-54006 Thessaloniki, Greece
来源：
LEUKEMIA RESEARCH | 2015年 / 39卷
关键词：
D O I：
10.1016/S0145-2126(15)30284-8
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
283
引用
收藏
页码：S141 / S141
页数：1
相关论文
共 50 条
  • [21] Disparate effect of beige mutation on cytotoxic function between natural killer and natural killer T cells
    Bannai, M
    Oya, H
    Kawamura, T
    Naito, T
    Shimizu, T
    Kawamura, H
    Miyaji, C
    Watanabe, H
    Hatakeyama, K
    Abo, T
    IMMUNOLOGY, 2000, 100 (02) : 165 - 169
  • [22] Natural killer cells and natural killer-T cells in patients with renal transplantation
    Hoppe, Anett
    Kamprad, Manja
    Wegmann, Claudia
    Woetzel, Michael
    Hauss, Johann
    Emmrich, Frank
    Fangmann, Josef
    Sack, Ulrich
    LABORATORIUMSMEDIZIN-JOURNAL OF LABORATORY MEDICINE, 2008, 32 (03): : 140 - 147
  • [23] REQUIREMENT FOR NATURAL-KILLER-CELLS IN THE INDUCTION OF CYTOTOXIC T-CELLS
    KOS, FJ
    ENGLEMAN, EG
    JOURNAL OF IMMUNOLOGY, 1995, 155 (02): : 578 - 584
  • [24] Natural killer cells with NKDG2D cytotoxicity but NKp30-dull phenotype predominate in myelodysplastic syndrome (MDS).
    Bai, FQ
    Painter, JS
    Alan, C
    Zou, JX
    Wei, S
    Djeu, JY
    List, AF
    Epling-Burnette, PK
    BLOOD, 2005, 106 (11) : 959A - 959A
  • [25] TET2/IDH mutations in myelodysplastic syndrome patients disrupts Natural Killer cells biology
    Boy, Maxime
    Bisio, Valeria
    Zhao, Lin Pierre
    Lereclus, Emilie
    Guidez, Fabien
    Retiere, Christelle
    Clappier, Emmanuelle
    Balabanian, Karl
    Toubert, Antoine
    Fenaux, Pierre
    Ades, Lionel
    Dulphy, Nicolas
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2021, 51 : 44 - 44
  • [26] Effect of electric foot shock and psychological stress on activities of murine splenic natural killer and lymphokine-activated killer cells, cytotoxic T lymphocytes, natural killer receptors and mRNA transcripts for granzymes and perforin
    Li, Q
    Liang, ZF
    Nakadai, A
    Kawada, T
    STRESS-THE INTERNATIONAL JOURNAL ON THE BIOLOGY OF STRESS, 2005, 8 (02): : 107 - 116
  • [27] Dysregulation of natural killer cells' receptor expression and cytotoxic function by hydroxychloroquine
    Elemam, Noha M.
    Talaat, Iman M.
    Maghazachi, Azzam A.
    JOURNAL OF IMMUNOLOGY, 2023, 210 (01):
  • [28] Mesenchymal stem cells inhibit the formation of cytotoxic T lymphocytes, but not activated cytotoxic T lymphocytes or natural killer cells
    Rasmusson, I
    Ringdén, O
    Sundberg, B
    Le Blanc, K
    TRANSPLANTATION, 2003, 76 (08) : 1208 - 1213
  • [29] Natural killer and natural killer T-like cells in splenectomised patients
    Grywalska, Ewelina
    Markowicz, Justyna
    Siwicka, Dorota
    Pasiarski, Marcin
    Surdacka, Agata
    Grafka, Agnieszka
    Malec, Agnieszka
    Bilski, Mateusz
    Roman, Tomasz
    Rolinski, Jacek
    CENTRAL EUROPEAN JOURNAL OF IMMUNOLOGY, 2013, 38 (03) : 372 - 379
  • [30] Abnormal populations and functions of natural killer cells in patients with myelodysplastic syndromes
    Zhang, Wei
    Xie, Xinyan
    Mi, Huijing
    Sun, Jinwan
    Ding, Shaoxue
    Li, Lijuan
    Liu, Hui
    Wang, Huaquan
    Fu, Rong
    Shao, Zonghong
    ONCOLOGY LETTERS, 2018, 15 (04) : 5497 - 5504
12345